SSAA09E2 | B2723

SSAA09E2 is a novel inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).

SSAA09E2 is a novel inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).SARS-CoV replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).

B2723 | SSAA09E2 DataSheet

Alternate Name/Synonyms: N-[[4-(4-Methyl-1-piperazinyl)phenyl]methyl]-5-isoxazolecarboxamide

Appearance: Crystalline solid

Formulation:

CAS Number: 883944-52-3

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₆H₂₀N₄O₂

Molecular Weight: 300.36

Cell-Permeable?: TRUE

Purity: ≥98% by HPLC

Solubilities: DMSO

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: A novel inhibitor of SARS-CoV replication

MDL Number:

PubChem CID:

SMILES: CN1CCN(CC1)C2=CC=C(C=C2)CNC(=O)C3=CC=NO3

InChi: InChI=1S/C16H20N4O2/c1-19-8-10-20(11-9-19)14-4-2-13(3-5-14)12-17-16(21)15-6-7-18-22-15/h2-7H,8-12H2,1H3,(H,17,21)

InChi Key: OMRXBNSVRJWWAZ-UHFFFAOYSA-N